Experimental Herpes Simplex Virus Type 1 Encephalitis: Treatment With 5-Trifluoromethyl-2'-Deoxyuridine

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.11.2.307
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Effect of Treatment With 5-Ethyl-2'-Deoxyuridine on Herpes Simplex Virus Encephalitis in Normal and Immunosuppressed Mice

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1978English

Ribonucleotide Reductase of Herpes Simplex Virus Type 2 Resembles That of Herpes Simplex Virus Type 1.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1984English

Topical Treatment of Cutaneous Herpes Simplex Virus Infection in Hairless Mice With (E)-5-(2-Bromovinyl)-2'-Deoxyuridine and Related Compounds.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1984English

Treatment of Herpes Simplex Virus Types 1 and 2 Encephalitis in Mice With 9- -D-Arabinofuranosyladenine

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1973English

Herpes Simplex Virus Type-2 Encephalitis in Peripartum Period Preceded by Hepatitis.

Japanese Journal of Medicine
1987English

Herpes Simplex Virus Encephalitis: An Update

Mediterranean Journal of Infection, Microbes and Antimicrobials
Infectious DiseasesImmunologyMicrobiologyMicrobiology
2019English

GP45 Autoimmune Encephalitis Triggered by Herpes Simplex Virus 1 Infection

2019English

Herpes Simplex Encephalitis

JAMA - Journal of the American Medical Association
Medicine
1968English

Herpes Simplex Encephalitis

The Lancet
Medicine
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy